- Bioventus press release (NASDAQ:BVS): Q1 Non-GAAP EPS of $0.08 beats by $0.06.
- Revenue of $123.88M (-4.3% Y/Y) beats by $1.17M.
- Q1 reported revenue of $123.9 million declined 4.3%; Organic revenue advanced 5.0%
- 2025 Financial Guidance:
- Net sales of $560 million to $570
